Metabase
Blockchain and smart op-codes platform
What is it?
Genexi accelerates the transition of cutting-edge biotech projects from research to the market. GEN token is qualified as a utility token. The token will be used as a medium of exchange within the ecosystem.
ICO Countries Not Allowed
The following countries are not allowed to participate in the crowdsale:
- USA
Official Explainer Video
GENEXI Details
Blockchain Ethereum (ERC20)
Team Location Switzerland
Pre-ICO Details
Status | Pre-Sale Ended
Pre-ICO Start Date May 15
Pre-ICO End Date May 31
Pre-ICO Conversion
1 GEN = 0.01 USD
Pre-ICO Bonus
20%
ICO Details
Status | Ends in 10 days
KYC Required
ICO Start Date Jun 1
ICO End Date Jul 31
Soft Cap 20,000,000 USD
Hard Cap 70,000,000 USD
Total Supply 12,000,000,000 GEN
Investor Supply 8.400,000,000 GEN
ICO Conversion
1 GEN = 0.01 USD
Bonus Structure
17% Round 1 01.06 – 14.06
9% Round 2 15.06 – 28.06
5% Round 3 29.06 – 12.07
2% Round 4 13.07 – 31.07
Supply Distribution
70% Public Distribution
10% Long-term Foundation Budget
15% Founders, Team
5% Advisors and Early Contributors
----------
*Unsold tokens will be burned.
GENEXI Founding Team
Co-Founder, CEO
Co-Founder, COO
Managing Director
Head of Medical Research
Head of Finance
Head of Operations
Head of Strategy
Head of Business Development
Head of Research
Head of HR